Full Text View
Tabular View
No Study Results Posted
Related Studies
A Study of the Safety and Effectiveness of Infliximab for the Treatment of Psoriatic Arthritis
This study has been completed.
Study NCT00051623   Information provided by Centocor, Inc.
First Received: January 14, 2003   Last Updated: November 26, 2008   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Arthritis, Psoriatic
Additional conditions recognized in this trial
Arthritis
More general conditions related to this trial
Bone Diseases
Joint Diseases
Musculoskeletal Diseases
Psoriasis
Skin Diseases
Skin Diseases, Papulosquamous
Spinal Diseases
Spondylarthritis
Spondylarthropathies
Interventions listed in this trial
Infliximab
More general drug interventions related to this trial
Anti-Inflammatory Agents
Antirheumatic Agents
Dermatologic Agents
Gastrointestinal Agents
Pharmacologic Actions
Therapeutic Uses
Sponsors listed in this trial
Centocor, Inc.


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services